The Latest Presentations by

Full Poster Download Preliminary efficacy and safety results from the TATCIST trial: A PSMA-directed targeted alpha therapy with FPI-2265 (225Ac-PSMA-I&T)…

Full Poster Download FPI-2068: A novel anti-EGFR/cMET, alpha-particle emitting, radioimmunoconjugate for cancer therapy

Full Poster Download Dose-Escalation Study of [225Ac]-FPI-1434 (FPI-1434) in Patients With IGF-1R-Expressing Advanced Solid Tumors: Preliminary Pharmacology and Dosimetry Results

Full Poster Download EGFRvIII-Targeted Alpha Therapy Shows Significant Therapeutic Efficacy as Both a Single-Agent and in Combination with Standard of…

Full Poster Download TEM-1 targeted alpha therapeutic [225Ac]-FPI-1848 induces regression in pre-clinical sarcoma xenograft models

Full Poster Download NTSR1-targeted Alpha Therapeutic [225Ac]-FPI-2059 Induces Growth Inhibition in a Preclinical Colorectal Tumor Model

Full Poster Download Adaptation of an Investigational β-Emitting NTSR1-Targeted Radiopharmaceutical into the Targeted Alpha Therapeutic [225Ac]-FPI-2059

Full Presentation Download Impact of Pre-Administration of Anti-IGF-1R Antibody FPI-1175 on the Dosimetry, Tumor Uptake, and Pharmacokinetics of the IGF-1R…

Full Presentation Download NTSR1 Targeted Alpha Therapeutic [225Ac]-FPI-2059 Induces Regression in Preclinical Colorectal Xenograft Model

Full Presentation Download FGFR3 Targeted Alpha Therapeutic [225 Ac]-FPI-1966 Induces Regression in Preclinical Bladder Xenograft Model